Carmel, IN, United States of America

Jian Eric Hong

USPTO Granted Patents = 4 


Average Co-Inventor Count = 8.1

ph-index = 2

Forward Citations = 23(Granted Patents)


Location History:

  • Foster City, CA (US) (2008)
  • Carmel, IN (US) (2007 - 2009)

Company Filing History:


Years Active: 2007-2009

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Jian Eric Hong - Innovator in Pharmaceutical Chemistry**

Introduction

Jian Eric Hong is a prominent inventor located in Carmel, Indiana, specializing in pharmaceutical chemistry. He holds a total of four patents, each contributing to advancements in treating neuropsychiatric disorders and enhancing cognitive function. His work demonstrates a commitment to understanding and improving the efficacy of treatments for serious cognitive conditions.

Latest Patents

Among his latest patents are groundbreaking inventions focused on glutamate receptors. One notable patent titled "Pyrrole and pyrazole derivatives as potentiators of glutamate receptors" details compounds that show promise in treating schizophrenia, Alzheimer's disease, and other cognitive deficits. These compounds, along with their pharmaceutically acceptable salts, are specifically designed to act as potentiators on glutamate receptors, particularly in enhancing AMPA receptor activity. Another important patent is centered on "AMPA receptor potentiators," outlining formulations and methods for using these compounds effectively in therapeutic applications.

Career Highlights

Jian Eric Hong plays a significant role at Eli Lilly and Company, a leading entity in pharmaceutical innovation. His research and inventions have the potential to transform treatment protocols for various neurodegenerative and psychiatric disorders. Throughout his career, he has remained dedicated to scientific discovery and the practical application of his inventions.

Collaborations

Jian has collaborated with esteemed colleagues, including Albert Kudzovi Amegadzie and Kevin Matthew Gardinier. These partnerships enhance not only the scope of his research but also contribute to a collective advancement in the field of pharmacology, allowing for a broader approach to tackling pressing health issues.

Conclusion

Jian Eric Hong stands as a figure of innovation in pharmaceutical chemistry through his contributions to scientific research and patent development. His focus on glutamate receptor potentiators opens new avenues for effectively addressing cognitive impairments linked to severe mental health and neurodegenerative disorders. His continued work is anticipated to drive positive changes in therapeutic strategies, benefiting countless individuals affected by these conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…